SCHEMBL6163791

SCHEMBL6163791

COCOC1CCN(C(=O)C(N)Cc2ccccc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 2/20 0.55
F2 P00734 1/20 0.52
PRSS1 P07477 1/20 0.52
HDAC8 Q9BY41 3/20 0.52
POLB P06746 1/20 0.49
OPRK1 P41145 1/20 0.49
DPP4 P27487 2/20 0.49
REN P00797 3/20 0.48
ROCK2 O75116 1/20 0.48
CYP3A4 P08684 1/20 0.48
AKT1 P31749 1/20 0.47
AKT2 P31751 1/20 0.47
AKT3 Q9Y243 1/20 0.47
FAP Q12884 1/20 0.47
DPP8 Q6V1X1 1/20 0.47
DPP9 Q86TI2 1/20 0.47
DPP7 Q9UHL4 1/20 0.47
SMYD3 Q9H7B4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9494667 1.00 OPRD1 (0.55) OPRD1F2PRSS1HDAC8POLB
SCHEMBL13540967 0.88 OPRD1 (0.60) OPRD1F2PRSS1HDAC8POLB
SCHEMBL7352495 0.87 REN (0.51) REN
SCHEMBL7317592 0.87 REN (0.51) REN
SCHEMBL7352491 0.87 REN (0.51) REN
SCHEMBL7361787 0.82 REN (0.59) REN
SCHEMBL9442934 0.82 REN (0.59) REN
SCHEMBL7360693 0.81 HPGD (0.66) OPRD1HDAC8POLBOPRK1DPP4
SCHEMBL7975223 0.81 HPGD (0.47) F2PRSS1REN
SCHEMBL7347289 0.81 KDM4E (0.49) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-5244910-A Treating hypertension, congestive heart failure ABBOTT LABORATORIES (US) 1993-09-14 US disclosed